充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Mechanical circulatory support devices in advanced heart failure: 2020 and beyond
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
The year in cardiology: heart failure: The year in cardiology 2019
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial

Original Research

2018 Apr;198:145-151.

JOURNAL：Am J Cardiol.

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Velazquez EJ, Morrow DA, DeVore AD et al.

4284

Keywords: sacubitril; valsartan; enalapril; NT-proBNP; acute Heart Failure episode

FULL TEXT PDF